It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2020.
2020 | Kolkata, West Bengal, India | ActiveNovo Medix Pharmaceutical Private Limited, a active private limited company, was established on 03 January 2020 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85100WB2020PTC235666. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹0.60 M and a paid-up capital of ₹0.60 M.
Employing 20 professional, Its leadership includes Aurobinda Banerjee (Whole-Time Director), Sabir Hossain (Additional Director), Khondaker Nurul Islam (Additional Director). Past directors included Aurobinda Banerjee, Abhijit Basu, Jyotirmoy Roy Karmakar. It holds ₹4.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 191 Debinibas Road, Ground Floor P.O - Motijheel, P.S. Dumdum, Kolkata, West Bengal, 700074.
U85100WB2020PTC235666
235666
03 January 2020
₹0.60 M
₹0.60 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Novo Medix Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aurobinda Banerjee | Whole-Time Director | 03 Jan 2020 | Current |
| Sabir Hossain | Additional Director | 27 Dec 2022 | Current |
| Khondaker Nurul Islam | Additional Director | 02 Aug 2021 | Current |
| Abhijit Basu | Managing Director | 03 Jan 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novo Medix Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.68% decrease. The company also saw a substantial fall in profitability, with a 51.8% decrease in profit. The company's net worth Soared by an impressive increase of 83.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Novo Medix Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Dec 2024 | Others | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Novo Medix Pharmaceutical has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Novo Medix Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Medix Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 4.00 M with Charge ID 101028710 was registered on 12 Dec 2024. was recorded as a recent event.
The activity Novo Medix Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Novo Medix Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
Progress on Sabir Hossain was appointed as a Additional Director was appointed as a Additional Director on 27 Dec 2022 & has been associated with this company since 2 years 11 months . was documented.
Khondaker Nurul Islam was appointed as a Additional Director was appointed as a Additional Director on 02 Aug 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
Aurobinda Banerjee was appointed as a Whole-time director was appointed as a Whole-time director on 03 Jan 2020 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
The CIN of Novo Medix Pharmaceutical Private Limited is U85100WB2020PTC235666.
Novo Medix Pharmaceutical Private Limited is headquartered at 191 Debinibas Road, Ground Floor P.O - Motijheel, P.S. Dumdum, Kolkata, West Bengal, 700074.
Novo Medix Pharmaceutical Private Limited was incorporated on 03 January 2020.
The current directors of Novo Medix Pharmaceutical Private Limited are
The primary industry of Novo Medix Pharmaceutical Private Limited is Trade.
Novo Medix Pharmaceutical Private Limited is unlisted.
The authorized capital of Novo Medix Pharmaceutical Private Limited is ₹0.60 M, and the paid-up capital is ₹0.60 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX